Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Heme Oxygenase System in Hematological Malignancies.
Li Volti G, Tibullo D, Vanella L, Giallongo C, Di Raimondo F, Forte S, Di Rosa M, Signorelli SS, Barbagallo I. Li Volti G, et al. Among authors: forte s. Antioxid Redox Signal. 2017 Aug 20;27(6):363-377. doi: 10.1089/ars.2016.6735. Epub 2017 May 19. Antioxid Redox Signal. 2017. PMID: 28257621 Review.
Heme oxygenase-2/adiponectin protein-protein interaction in metabolic syndrome.
Vanella L, Li Volti G, Guccione S, Rappazzo G, Salvo E, Pappalardo M, Forte S, Schwartzman ML, Abraham NG. Vanella L, et al. Among authors: forte s. Biochem Biophys Res Commun. 2013 Mar 22;432(4):606-11. doi: 10.1016/j.bbrc.2013.02.037. Epub 2013 Feb 21. Biochem Biophys Res Commun. 2013. PMID: 23438433 Free PMC article.
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy.
Romano A, Parrinello NL, Vetro C, Forte S, Chiarenza A, Figuera A, Motta G, Palumbo GA, Ippolito M, Consoli U, Di Raimondo F. Romano A, et al. Among authors: forte s. Br J Haematol. 2015 Mar;168(5):689-700. doi: 10.1111/bjh.13198. Epub 2014 Nov 7. Br J Haematol. 2015. PMID: 25376846 Free article. Clinical Trial.
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents.
Romano A, Parrinello NL, Consoli ML, Marchionni L, Forte S, Conticello C, Pompa A, Corso A, Milone G, Di Raimondo F, Borrello I. Romano A, et al. Among authors: forte s. Ann Hematol. 2015 Nov;94(11):1875-83. doi: 10.1007/s00277-015-2462-4. Epub 2015 Jul 31. Ann Hematol. 2015. PMID: 26223359 Free PMC article. Clinical Trial.
The non-canonical functions of the heme oxygenases.
Vanella L, Barbagallo I, Tibullo D, Forte S, Zappalà A, Li Volti G. Vanella L, et al. Among authors: forte s. Oncotarget. 2016 Oct 18;7(42):69075-69086. doi: 10.18632/oncotarget.11923. Oncotarget. 2016. PMID: 27626166 Free PMC article. Review.
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.
Stella S, Zammit V, Vitale SR, Pennisi MS, Massimino M, Tirrò E, Forte S, Spitaleri A, Antolino A, Siracusa S, Accurso V, Mannina D, Impera S, Musolino C, Russo S, Malato A, Mineo G, Musso M, Porretto F, Martino B, Di Raimondo F, Manzella L, Vigneri P, Stagno F. Stella S, et al. Among authors: forte s. Int J Mol Sci. 2019 May 6;20(9):2226. doi: 10.3390/ijms20092226. Int J Mol Sci. 2019. PMID: 31064152 Free PMC article.
214 results